Reports

Drug name	NICE TAs	Comments
Cefuroxime 5% eye drops (preserv-free)		Unlicensed. Ophthalmologist only.
Cefuroxime 5% powder		Unlicensed. Ophthalmologist only.
Cefuroxime nebulised		Hospital only
Cemiplimab	TA802: Cemiplimab for treating advanced cutaneous squamous cell carcinoma
Ceritinib	TA500 - Ceritinib for untreated ALK-positive non-small-cell lung cancer TA395 - Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer	For hospital use only
Certolizumab injection	TA186 - Rheumatoid arthritis - Certolizumab pegol TA375 - Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed TA574 - Certolizumab pegol for treating moderate to severe plaque psoriasis	Hospital use only
Cetaphen 10% topical ointment
Cetrorelix injection
Cetuximab infusion	TA172 - Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck TA145 - Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck TA439 - Cetuximab and panitumumab for previously untreated metastatic colorectal cancer TA118 - Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer TA473 - Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neck	National CDF list. For hospital use only.
Chenodeoxycholic acid capsules		Clinical Commissioning policy: Cholic acid and Chenodeoxycholic acid for treating inborn errors of bile and synthesis (all ages) (PDF)

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
Next page
Last page

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Reports